159 related articles for article (PubMed ID: 3278747)
1. Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.
van Dongen JJ; Krissansen GW; Wolvers-Tettero IL; Comans-Bitter WM; Adriaansen HJ; Hooijkaas H; van Wering ER; Terhorst C
Blood; 1988 Mar; 71(3):603-12. PubMed ID: 3278747
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage.
Campana D; Thompson JS; Amlot P; Brown S; Janossy G
J Immunol; 1987 Jan; 138(2):648-55. PubMed ID: 3098852
[TBL] [Abstract][Full Text] [Related]
3. [T cell differentiation model based on the expression of T cell receptor chains and genes--study in the human leukemia/lymphoma cell lines].
Matsuo Y; Ariyasu T; Minowada J
Hum Cell; 1990 Oct; 3(3):201-12. PubMed ID: 2076429
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
van Dongen JJ; Quertermous T; Bartram CR; Gold DP; Wolvers-Tettero IL; Comans-Bitter WM; Hooijkaas H; Adriaansen HJ; de Klein A; Raghavachar A
J Immunol; 1987 Feb; 138(4):1260-9. PubMed ID: 3100631
[TBL] [Abstract][Full Text] [Related]
5. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors.
Mingari MC; Poggi A; Biassoni R; Bellomo R; Ciccone E; Pella N; Morelli L; Verdiani S; Moretta A; Moretta L
J Exp Med; 1991 Jul; 174(1):21-6. PubMed ID: 1711562
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against a "Pan-T-cell" antigen expressed by thymocytes, peripheral T-lymphocytes and T-cell leukemias.
Carrel S; Gross N; Heumann D; Sekaly RP; Girardet C; Schmidt-Kessen A; Mach JP
Mol Immunol; 1984 Oct; 21(10):831-40. PubMed ID: 6438496
[TBL] [Abstract][Full Text] [Related]
7. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
8. T cell differentiation stages identified by molecular and immunologic analysis of the T cell receptor complex in childhood lymphoblastic leukemia.
Mirro J; Kitchingman G; Behm FG; Murphy SB; Goorha RM
Blood; 1987 Mar; 69(3):908-12. PubMed ID: 3101767
[TBL] [Abstract][Full Text] [Related]
9. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.
Levy R; Dilley J; Fox RI; Warnke R
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6552-6. PubMed ID: 316541
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characteristics of the CD3 (T3) molecular complex on human thymocytes.
Tsoukas CD; Landgraf B; Bentin J; Lamberti JF; Carson DA; Vaughan JH
J Immunol; 1987 Jun; 138(11):3885-90. PubMed ID: 3108378
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
12. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines.
Koníková E; Babusíková O; Kusenda J; Glasová M
Neoplasma; 1992; 39(6):337-42. PubMed ID: 1491722
[TBL] [Abstract][Full Text] [Related]
13. Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies.
Link MP; Stewart SJ; Warnke RA; Levy R
J Clin Invest; 1985 Jul; 76(1):248-53. PubMed ID: 2410458
[TBL] [Abstract][Full Text] [Related]
14. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
15. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
16. Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells.
Mingari MC; Poggi A; Bellomo R; Pella N; Moretta L
Int J Clin Lab Res; 1991; 21(2):176-8. PubMed ID: 1840028
[TBL] [Abstract][Full Text] [Related]
17. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
[TBL] [Abstract][Full Text] [Related]
18. Rabbit antisera to cell lines RC2a and U937: antigens expressed on human leukaemic cells of myeloid, monocyte and T-lymphocyte lineage.
Pilkington G; Jacobs D; Mackenzie S; Bradley R; Hunter S; Jose D
Aust J Exp Biol Med Sci; 1982 Oct; 60 (Pt 5)():479-92. PubMed ID: 6819843
[TBL] [Abstract][Full Text] [Related]
19. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.
Schroff RW; Foon KA; Billing RJ; Fahey JL
Blood; 1982 Feb; 59(2):207-15. PubMed ID: 7034809
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
